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ABSTRACT
Polychlorinated biphenyls (PCBs) are persistent organic pollutants that have been
associated with fatty liver disease, cardiovascular diseases, and other metabolic
dysfunctions. Our laboratory group previously demonstrated that exposures to PCBs led
to sex-dependent liver outcomes with female mice showing higher susceptibility to PCBinduced liver toxicity. Some of the underlying mechanisms driving these sex-dependent
outcomes that were identified included PCB-modulated endocrine disruption. However,
the PCB effects on the gut microbiome and the gut liver axis have not been investigated.
Therefore, the objective of the current study is to identify PCB-induced changes in the gut
microbiome and identify if this could be a cause for the observed sex-dependent PCB
toxicity. Male and female C57BL6 mice were exposed to a mixture of PCBs for two weeks;
cecal and ileal samples were isolated at euthanasia. 16S sequencing was performed and
RT-PCR was used to examine ileal gene expression. The metagenomics results
demonstrated significant sex differences in bacterial composition with PCB-exposed
female mice exhibiting the lowest alpha diversity. In terms of beta diversity, there was a
predominant sex effect driving the differences while PCB effects were subtler in both
sexes. Additionally, assessment of ileal gene expression demonstrated that the PCBexposed female mice had lower expression for genes encoding gut barrier proteins,
namely Cldn2 and Muc2. With regards to inflammatory responses, PCB-exposed female
mice showed decreased gene expression for the antimicrobial peptide, namely Tff3,
thereby implicating an unhealthy mucosal environment. Taken together, the results
demonstrated that PCB exposure impacted the gut microbiome and gut function in a sexdependent manner, thus confirming the existence of sex differences on gut microbiota

4

with environmental exposures. Future studies will include identification of key bacterial
phyla that were altered with sex and exposure and correlating them with hepatic toxicity
endpoints.

5

LAY SUMMARY
Polychlorinated biphenyls (PCBs) are hazardous substances found in the
environment that have been linked to a variety of health problems in people who are
exposed to them. Liver disease, reproductive abnormalities, and cardiovascular illnesses
are among the health consequences. While extensive studies have been done using
experimental models to investigate PCB-mediated organ damage and toxicity, little is
known about how PCBs behave in terms of their harmful effects in the context of sex and
gender. The goal of the proposed study is to understand how pollutants like PCBs can
alter the composition of gut bacteria, how these changes affect liver health, and whether
these changes are different in males and females. This research will help us determine
the association between different environmental pollutants with sex and gender, as well
as identify if men or women are more susceptible to PCB-related health effects.
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INTRODUCTION
Background
Polychlorinated biphenyls (PCBs) are halogenated aromatic hydrocarbons
belonging to the class of persistent organic pollutants. PCBs are also known as “forever
chemicals” because they are resistant to metabolism and biodegradation. PCB exposures
in humans have been associated with numerous diseases such as cancer, cardiovascular
complications, diabetes and liver disease (1). Due to their thermodynamic stability, they
were used as dielectric fluids in voltage transformers (capacitors) and other industrial
applications. In 1979, PCB production and use were banned in the US by Congress (Toxic
Substance Control Act). Despite being banned in the U.S. since the 1970s, PCBs were
still used world-wide, and their production and use were globally banned at the Stockholm
Convention in 2001. PCBs are still present in our environment and ecosystem due to their
resistance to biodegradation. The primary method of human exposure is through PCBladen food; due to the lipophilic nature of PCBs, they eventually bioaccumulate in adipose
tissue. Hence, they continue to be a risk to both wildlife and human health.
The structural composition of PCBs is typically chlorination on the biphenyl ring,
leading to coplanar and non-coplanar compounds, depending on the type of chlorine
substitution (2). Coplanar compounds are classified as “dioxin-like” as they are able to
activate the aryl hydrocarbon receptor (AhR), similar to the well-known chemical dioxin;
coplanar PCBs consist of low-molecular weight congeners. Non-coplanar congeners are
classified as “phenobarbital-like” or “non-dioxin-like” due to their ability to activate
constitutive androstane receptor (CAR); non-coplanar PCBs consist of high molecular
weight congeners. The Monsanto Corporation which was the primary company that
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produced PCBs in North America at its plant in Anniston, AL, commercially sold PCBs as
mixtures of congeners under the brand name “Aroclors”. The first-generation PCB
commercial mixture, known as Aroclor 1260, consisted of 60% chlorine by weight.
However, due to its toxic effects, it was replaced by second-generation PCB mixtures
such as Aroclor 1016, with a lower chlorine content. Nevertheless, because Aroclor 1260
is highly chlorinated and is comprised of many high molecular weight congeners, it is
resistant to metabolism, leading to bioaccumulation. The use of Aroclor 1260 is relevant
in our research because it mimics current PCB bioaccumulation patterns in humans.
PCBs exposures are associated with many diseases including non-alcoholic fatty
liver disease (NAFLD) and toxicant associated steatohepatitis (TASH) (3, 4). NAFLD is
fatty liver disease characterized by lipid accumulation in the liver or steatosis and
accompanied by inflammation (steatohepatitis). TASH is a form of NAFLD that is caused
by exposure to chemical pollutants or toxicants such as PCBs (5). Previous studies have
also reported liver disease prevalence within a known PCB-exposed population that
resided in Anniston, AL and this study population was named the Anniston Community
Health Survey (ACHS) population (6). In addition, experimental toxicology studies
examining the role of PCBs in liver diseases have also indicated the existence of sexdependent effects where female mice were more susceptible to PCB-induced TASH (7).
Mechanistically, PCBs are thought to exacerbate their toxic effects on the liver, in part,
through activation of CAR and pregnane-xenobiotic receptor (PXR), which are xenobiotic
receptors that function to detoxify drugs and foreign chemicals in the liver through the
activation of cytochrome P450s (8). These receptors play other roles in energy
metabolism, steatosis and regulating the gut microbiota.
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Recent studies have indicated that PCB exposure also caused gut microbiome
alterations which could potentially play a role in TASH (9, 10). However, little is known
about PCB effects on gut microbiome especially with low-dose, environmental exposures.
Also, the existence of sex differences in PCB-induced altered gut microbiome has not
been thoroughly studied. Therefore, the objective of the current study is to evaluate
changes in gut microbiome caused by toxicant exposures, namely polychlorinated
biphenyls (PCBs), and to identify the underlying sex differences.
We expected to observe differences in gut microbiota composition between male
and female mice in parameters such as alpha and beta diversity. We also expected PCB
exposures to change gut microbiota composition as well as gene expression of ileal
permeability and function markers such as tight junction proteins. Based on our previous
studies on liver endpoints, where PCB-exposed female mice were most susceptible to
fatty liver disease, we expected that there will be an interaction between sex and
exposure, wherein female mice have higher levels of microbiome alterations. Additionally,
we expected PCB-exposed female mice to have lower gene expression levels of ileal
barrier markers and higher level of inflammatory markers. Furthermore, the findings from
our project will help identify and address research gaps in environmental health sciences
pertaining to sex differences in PCB-induced altered gut microbiome.

Hypothesis
The central hypothesis of the current study is that exposures to environmental
toxicants such as PCBs can cause alterations in gut microbiome composition and ileal
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gene expression; furthermore, the effects of PCBs on gut microbiota differ between
sexes.
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MATERIALS AND METHODS
Animal Experimental Design
The animal study has already been performed by Wahlang et al (7). Briefly male
and female mice (n =10) were exposed to either corn oil (vehicle control) or a PCB mix
that was comprised of the commercial PCB mixture, Aroclor 1260 (20 mg/kg) and
PCB126 (20 μg/kg) for 2 weeks. The PCB mix was administered via oral gavage. At the
end of the study, mice were euthanized and tissues such as the liver, intestine and cecum
were harvested. The animal protocol was approved by the University of Louisville
Institutional Animal Care and Use Committee.

Bacterial DNA isolation
Microbial genomic DNA from cecal samples was isolated using the DNeasy Power
Soil Pro Kit (Qiagen, Germantown, MD, USA) and instructions were followed according
to the manufacturer’s manual. Approximately 200 mg of cecal sample was added to
Powerbead Pro tubes containing beads and CD 1 (Lysis Buffer) solution. The tubes were
then vortexed and centrifuged. The supernatant was transferred to a 2 mL microcentrifuge
tube and 200 µL of cold (8 °C) CD2 (inhibitor removal) solution was added. The solution
was then vortexed, centrifuged and the supernatant was transferred to a new 2 mL
microcentrifuge tube. 600 µL of CD3 (Binding Buffer) solution was added to the
supernatant solution and vortexed. 650 µL of this lysate was then added to an MB spin
column, and it was centrifuged. Flow-through was discarded and this step was repeated.
The MB spin column was then placed into a clean 2 mL collection tube. It was washed by
EA and C5 (wash) solution, respectively. The MB spin column was the placed into a new
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a 1.5 mL elution tube. 50-100 µL of C6 (elution buffer) solution was then added near the
white filter membrane and lastly, the solution was centrifuged, while the MB spin column
was discarded.

16S Metagenomic Sequencing Library Preparation and Sequencing Run
The cecal microbiota was analyzed using the Illumina MiSqeq technology, focusing
on V3 and V4 of 16S ribosomal RNA. Libraries were prepared using the Illuminas 16S
library preparation guide and Illumina’s Nextera Index Kit (FC-121-1012). Initially, the
isolated microbial genomic DNA was quantified using the Quibot Broad Range (BR)
Assay in a Quibot 2.0 Fluorometer. Amplicon PCR was carried out to amplify the 16S
variable region of the genomic DNA using primers and overhang adaptors. Amplicon PCR
was cleaned up using AMPure XP beads. Index PCR was then performed to attach dual
indices and Illumina sequencing adapters using the Nextera XT Kit (FC-121-1012).
Clean-up was then repeated. Sequencing libraries were then aliquoted and mixed to
generate pooled libraries and a Bioanalyzer was used to quantify DNA amount. The
genomic DNA library was then denatured and combined with the PhiX control library.
Using a Nano-300 cycle test chip (MS-103-1001), sequencing was then performed to
confirm sample concentrations followed by Illumina MiSeq Reagents Kit v3 (600 cycles)
(MS-12-3003) at 9 pM and 30% PhIX.

Microbiome Sequencing Data Analysis
Quality control of the raw sequence data was carried out using FastQC (version
0.10.1). The sequence data were then trimmed and further analyzed using Quantitative
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Insights into Microbial Ecology (QIIME 2) (version 2019.4). A tree was generated for
phylogenetic diversity analyses using the representative sequences and core diversity
analyses including alpha and beta diversity were performed. Algorithms used to measure
alpha diversity were Shannon Index, observed_species (OTUs) and Faith_pd; algorithms
used to measure beta diversity included UniFrac and Jaccard. The Emperor tool was
used to explore the principal covariant analysis plot in the context of sample metadata
which is the distance between samples (beta diversity) using weighted and unweighted
UniFrac.

Gene expression analysis
RNA isolation, quantification and cDNA synthesis were performed on ileal samples
(n = 10) that have been isolated from mice using previously described methods (3). RTPCR was performed on the CFX384 TM Real-Time System (Biorad, Hercules, CA, USA)
using iTaq Universal Probes Supermix and TaqMan probes (Biorad, Hercules, CA, USA).
Gene expression levels were calculated according to the 2−ΔΔCt method (11). The levels
of mRNA were normalized relative to the levels of housekeeping genes and mean
expression levels in unexposed, male mice was set at 1. The primers that were evaluated
included i) genes encoding proteins involved in gut barrier integrity and function, namely,
Tight Junction Protein 1 (TJP1), Claudin 1, Claudin 2, Occludin, Vascular Endothelial (VE)
Cadherin (5), Mucin 1 (MUC1), Mucin 2 (MUC2), Fibroblast growth factor 15 (FGF15);
and ii) genes involved in inflammation, namely ileal Trefoil factor 3 (TFF3), Interleukin 6
(IL-6), Interleukin 10 (IL-10), Tumor necrosis factor alpha (TNFα) and Transforming
growth factor beta (TGF-β).
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Statistical Analyses for Sequence Data
Kruskal-Wallis test was used for pairwise comparisons between all experimental
groups for core metric analysis, and an FDR adjusted p-value (q-value) was used to infer
significance (p-value <0.05). For principal covariant analysis, the mean distance between
two groups was compared using multivariate analysis of variance (PERMANOVA), and
nonparametric p-values were calculated using 999 Monte Carlo permutations.

Statistical Analyses for RT-PCR results
Statistical comparisons were performed using GraphPad Prism version 9
(GraphPad Software Inc., La Jolla, CA). The gene expression data was analyzed via a
Two-Way ANOVA, for two factors, namely “Sex” and “PCBs” and their interactions. For
the ANOVA analysis, p-value <0.05 was considered statistically significant. Due to the
exploratory nature of the study, sub-group analyses for multiple comparisons were also
performed within the male and female groups (CON vs. PCB) using a t-test (p-value
<0.05).
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RESULTS
Alpha Diversity
Alpha diversity which represents the array of species within the designated
samples, was measured using QIIME metrics, specifically observed_species (OTUs –
observed taxonomical units), Faith_pd tree, and Shannon Index measurements. Box plots
graphically illustrating the number of species were plotted and these are represented in
Figures 1A (Shannon), 1B (OTUs), and 1C (Faith_pd). With the Shannon Index metric,
which considers species richness and abundance, there was a significant difference
between the PCB-exposed male group (M-PCB) in comparison to the female control
group (F-CON). However, with the observed_species (OTU) metric, which accounts only
for species abundance, there was a significant difference between the male (M-PCB) and
female (F-PCB) groups with PCB exposure. Importantly, for the OTUs metric, the PCBexposed female group displayed the lowest microbial alpha diversity among all the
groups. Finally, for the Faith_pd metric, which measures phylogenetic differences among
species, there were no significant differences between the groups.
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Figure 1. Effects of PCB exposure on alpha diversity in male and female mice. Alpha
diversity was measured using three QIIME metrics, namely A) Shannon Index, B)
observed_species (OTUs), and C) Faith_pd. Kruskal-Wallis test was performed for
pairwise comparison between different groups for faith_pd. q-value <0.05 denotes
statistical significance in bacterial diversity between the two groups.
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Beta Diversity
Beta diversity was computed to compare how each group of samples differed
relative to other samples analyzed. Both unweighted and weighted variants of UniFrac
were used to measure the distance between the pairs of samples. Unweighted UniFrac
accounts for presence or absence of taxa across individual systems. In contrast, weighted
UniFrac takes into account the abundance of each taxa across individual samples in
addition to the absence or presence of taxa. In addition, Jaccard algorithm, which
measures similarity of bacterial composition between samples, was also employed to
measure beta diversity. The matrix for both weighted and unweighted UniFrac as well as
Jaccard was visualized using the principle co-variant analyses (PCA). The plots resulted
in three PCA coordinates, namely axis 1, 2 and 3. This is a 3-dimensional representation
of the acquired data as represented in Figure 2A, Figure 3A and Figure 4A. Results from
the PERMANOVA analysis, which compared significance differences between groups,
are represented in Figure 2B, Figure 3B and Figure 4B.

According to the weighted and unweighted UniFrac results, there was a significant
difference in beta diversity that resulted from both sex and PCB exposure effects. Firstly,
there was a difference between the males and females for the unweighted (qvalue=0.008) and weighted (q-value=0.006) results. There was also a significant
difference between the males and females, with PCB exposure, for both unweighted (qvalue=0.003) and weighted (q-value=0.044) results. Significant differences were
observed across all groups with Jaccard.
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A. Beta Diversity – Unweighted UniFrac (With Ellipse)

2B. Beta Diversity – Unweighted
Unifrac (with ellipse)
B. PERMANOVA
Analysis foranalysis
Unweighted UniFrac
Permanova

Comparisons
q-value
Group 1 Group 2
F-CON F-PCB 0.124
F-CON M-CON 0.008
F-CON M-PCB 0.003
F-PCB M-CON 0.009
F-PCB M-PCB 0.003
M-CON M-PCB 0.038
Figure 2. Effects of PCB exposure on beta diversity in male and female mice. A)
Beta diversity was computed by measuring distance between pairs of samples using
unweighted variant of UniFrac and matrix visualized with principal covariant analysis. B)
Table depicting results obtained from the PERMANOVA pairwise test. q-value <0.05
denotes statistical significance in bacterial diversity between the two groups.
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A. Beta Diversity – Weighted UniFrac (With Ellipse)

3B. Beta Diversity – Weighted Unifrac
(with ellipse)
Permanova analysis
B. PERMANOVA Analysis for Weighted UniFrac

Comparisons
q-value
Group 1 Group 2
F-CON F-PCB 0.112
F-CON M-CON 0.006
F-CON M-PCB 0.006
F-PCB M-CON 0.112
F-PCB M-PCB 0.044
M-CON M-PCB 0.112
Figure 3. Effects of PCB exposure on beta diversity in male and female mice. A)
Beta diversity was computed by measuring distance between pairs of samples using
weighted variant of UniFrac and matrix visualized with principal covariant analysis. B)
Table depicting results obtained from the PERMANOVA pairwise test. q-value <0.05
denotes statistical significance in bacterial diversity between the two groups.
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A. Beta Diversity – Jaccard (With Ellipse)

Jaccard (with ellipse)

B. PERMANOVA Analysis for Jaccard

Permanova analysis
Comparisons
q-value
Group 1 Group 2
0.002
F-CON F-PCB
F-CON M-CON 0.002
F-CON M-PCB 0.002
F-PCB M-CON 0.002
F-PCB M-PCB 0.002
M-CON M-PCB 0.017

Figure 4. Effects of PCB exposure on beta diversity in male and female mice. A)
Beta diversity was computed using the Jaccard algorithm which measures the similarities
between the samples. B) Table depicting results obtained from the PERMANOVA
pairwise test. q-value <0.05 denotes statistical significance in bacterial diversity between
the two groups.
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Hepatic Gene Expression
To further investigate the impact of PCB exposure on gut function within the female
and male groups, and to further identify if the gut barrier properties were affected due to
the altered microbiome, specific ileal markers of gut permeability and function were
assessed. The ileum was specifically chosen for this study because it is the most
immunologically active area of the gut and has a high sensitivity to alterations in barrier
function (12). Ileal mRNA levels of tight junction protein 1 (Tjp1) was initially examined.
Tjp1 is the gene encoding for zonula occludens-1, a scaffolding protein that connects tight
junction trans-membrane proteins like claudins (Cldn1,2) and occludin (Ocln) to the actin
cytoskeleton (13). Our RT-PCR results demonstrated there were no significant
differences in Tjp1 mRNA levels (Figure 5A). Further analysis of other gut barrier proteins
demonstrated that PCB exposure decreased both Cldn1 and Cldn2 mRNA levels (Figures
5B and 5C). Compared to their respective baseline groups, PCB-exposed male mice did
not show significant differences for either Cldn1 or Cldn2; however, there was a significant
decrease in Cldn1 expression in the PCB-exposed female group compared to their
unexposed female counterparts. Similar to Cldn2, there was a decrease in Ocln gene
expression with PCB exposure in the female group (Figure 5D). Precedingly, we
examined the adhesion molecule vascular endothelial cadherin-5 (Chd5), and mucus gelforming proteins Mucin 1 and 2 (Muc1 and Muc2). There were no observed differences
between the control and exposed groups for Cdh5 (Figure 5E) for either males or females.
However, there was a non-significant trend (p-value=0.0778) for decreased Muc1
expression with PCB exposure (Figure 5F); furthermore, sub-group analysis revealed that
the PCB-exposed female mice also showed a non-significant trend for decreased Muc1
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expression (p-value=0.067). In terms of Muc2, the PCB-exposed female group showed
significantly lower expression levels (Figure 5G).
Additionally, we examined expression levels of intestinal antimicrobial factors,
specifically Trefoil Factor 3 (Tff3) (Figure 6A), and mucosal inflammatory markers and
cytokines, namely tumor necrosis factor alpha (Tnfa), transforming growth factor beta
(Tgfb), interleukin 6 (Il-6) and interleukin 10 (Il-10) (Figure 6B - 6E). While there was a
PCB effect for decreased Tff3 expression, there were however no significant differences
for the other cytokines and markers. Interestingly, sub-group analysis demonstrated that
the PCB-exposed female mice showed a non-significant trend for decreased IL-6 gene
expression (p-value=0.0755).
Lastly, the hepatic expression of the gene encoding Fgf-15 was evaluated. Fgf-15
is a fibroblast growth factor secreted by intestinal epithelial cells and aids in hepatocyte
growth, bile acid homeostasis, as well regulating levels of glucose and lipid metabolism
(14). There was a sex-dependent effect for Fgf15 gene expression with female mice
having higher expression levels (Figure 6F). However, there was no reported PCB effect.
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Figure 5. Effects of sex and PCB exposure on ileal permeability markers. Ileal mRNA
levels for genes encoding proteins involved in maintenance of barrier integrity and
intestinal inflammation/function including (A) Tjp1, (B) Cldn1, (C) Cldn2, (D) Ocln, (E)
Cdh5, (F) Muc1, and (G) Muc2 were measured using RT- PCR. Values were normalized
to male control mice (M-CON) and presented as mean ± SEM, p< 0.05. An ANOVA table
with 2-way statistics are also presented
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Figure 6. Effects of sex and PCB exposure on ileal inflammatory markers and
function. Ileal mRNA levels for genes encoding proteins involved in maintenance of
intestinal inflammation and function including (A) Tff3, (B) Il6, (C) Il10 and (D) Fgf15 were
measured using RT-PCR. Values were normalized to male control mice (M-CON) and
presented as mean ± SEM, p< 0.05. An ANOVA table with 2-way statistics are also
presented.
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DISCUSSION
The underlying mechanisms of toxicity caused by PCBs in the liver have been
studied thoroughly, with main mechanisms being associated with activation of hepatic
receptors, such as AhR, CAR and PXR (4). Nevertheless, there are additional
mechanisms recently reported that include epigenetic modifications, molecular signaling
disruption and microbiome alterations that still warrant further investigation. Importantly,
the impact of PCB exposures on the relationship between the liver and gut microbiome is
still largely understudied.
The gut-liver axis refers to the relationship between the gut and its microbiota, and
the liver, due to integration of signals directed by dietary, genetic, and environmental
factors. This interaction is founded by the portal vein, which provides access for gutderived product to the liver while the liver feedback route provides access to the bile and
antibody secretions to the intestine. Particularly, the interaction between the gut and liver
depends on the mucosal and vascular barrier of the intestine, also known as the gut
barrier, thereby impeding the distribution of bacteria and toxins (15). Microbial regulation
is pertinent to maintaining the homeostasis of the gut-liver axis, as it plays an important
role in sustaining the microbial communities within the intestine.
A certain number of toxicological studies have looked at the impact of dioxin-like
PCBs

on

the

gut

microbiome.

Specifically,

PCB

126

increased

the

Firmicutes:Bacteroidetes ratio; decreased the intestinal bacterial diversity and decreased
organokines, such as glucagon peptide 1 (GLP-1) (16, 17). PCB 126 reduction in gut
diversity was associated with fifteen different NAFLD biomarkers, such as hepatic
inflammation, steatosis, and metabolism (17). Exposure to another dioxin-like PCB,
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namely PCB 77, also led to increased Firmicutes:Bacteroidetes ratio, as well as serum
bile acids, hepatic steatosis, inflammation, and fibrosis (18). In addition, studies
investigating non-dioxin-like PCBs and their impact on the gut microbiome have also
reported that Aroclor 1260 exposure led to altered alpha and beta diversity in mouse
models (9). A unique aspect of our current study is that we are assessing the impact of a
mixture of PCBs that consist of both dioxin-like and non-dioxin-like congeners and is
therefore, more environmentally relevant, since people are exposed to both classes.
Our results thus far indicate that there were significant microbiome alterations
regarding the alpha diversity, based on sex and PCB exposure. Importantly, the alpha
diversity findings showed that the PCB-exposed female group had the lowest diversity,
implicating that PCB exposure in the female mice drastically reduced the bacterial variety.
According to reported literature, a decrease in alpha diversity is often associated with
unhealthy conditions or diseased states including obesity and NAFLD (19). Indeed, in our
study, when we were investigating liver end points in this model, we observed that the
PCB-exposed female mice have more exacerbated hepatic injury, inflammation, and
steatosis. This, in part, validated our hypothesis that there is an interaction between the
gut and liver, driving these sex-dependent toxicities with PCB exposure. With regard to
beta diversity, there were also observable sex differences, as both males and females
behave differently in terms of gut microbiome and the addition of PCB exposure
exacerbated the difference reported in beta diversity.
Through the assessment of the gut barrier functions and inflammation using RTPCR, we discovered that certain gut barrier markers were altered with PCB exposure,
and this effect was more predominant in PCB-exposed female mice. Indeed, the gene
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expression for the gut barrier proteins, namely Mucin 2 and Occludin, were decreased in
the exposed female group. Mucin 2 forms the skeleton of the intestinal mucus and covers
and protects the intestinal tract from self-digestion and numerous microorganisms (20)
while occludin plays an integral role in the maintenance of tight junction assembly (21).
Surprisingly, Claudin-2, which is expressed in the tight junctions of leaky epithelia (22),
was also decreased in the exposed female group. Nonetheless, the results demonstrated
a difference in gene expression for proteins that regulate gut barrier function and this
needs to be further investigated.
In the current study, there were no significant differences observed in inflammatory
markers. A potential reason for this could be the short-term duration of PCB exposure in
the current study. We hypothesized that a longer duration of exposure would lead to a
pro-inflammatory state in the PCB-exposed females. However, PCB-exposed females did
exhibit lower mRNA levels of Tff3, the gene encoding the antimicrobial peptide TFF3.
Intestinal Tff3 was recently demonstrated to play an important role in reducing gut
permeability, and alleviating liver damage and administering Tff3 is potentially considered
a therapeutic strategy for non-alcoholic steatohepatitis (23).
The overall results so far are in concordance with our previously reported sexdependent PCB effects where we demonstrated that female mice were more susceptible
to PCB-mediated liver injury. The current results suggest that a potential mechanism that
may explain the observed liver outcomes is due to female mice acquiring a different
microbial profile than males. Additional analyses of the particular phyla influencing these
differences will be further evaluated. Another potential mechanism that will require further
elucidation is how the different bacteria crosstalk with PCB receptors such as AhR and
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CAR. Hepatic proteomic measurements were previously performed for this study (data
not shown), and the analysis revealed that PCB-exposed female mice had higher protein
levels of the AhR targets, namely flavin monooxygenases (FMOs). It is well-known that
one of the FMOs, namely FMO3, has an important relationship with the gut microbiome
in metabolizing the food derivative trimethylamine to trimethyl amine N-oxide (TMAO) (24,
25). Increased levels of TMAO have been associated with metabolic dysfunction in
cardiovascular disease (26). The role of the AhR, gut microbiome and metabolic and
hepatic dysfunction in female mice warrant further investigation. Moreover, our research
group has previously shown that PCB interactions with hepatic nuclear receptors such as
CAR and PXR also drive gut microbiome changes in diet-induced obese male mice (9).
These interactions will also be evaluated in the current study using integrated proteomicsmetagenomics analyses.

34

CONCLUSION
To summarize, our results thus far indicate that sex played a significant role in
dictating PCB-induced gut microbiome alterations. Additionally, examination of ileal gene
expression provided further evidence that PCB effects on gut barrier properties were sexdependent, given that female mice were more susceptible to these PCB-induced effects.
While the study is highly novel as it is one of the first studies to examine sex differences
in gut microbiome with PCB exposures, it is however not without limitations. The exposure
study was acute in nature, and does not reflect long-term exposures that occur in humans
today. Also, estrus cycle in female mice was not monitored over the study period.
Importantly, the results so far do not provide information on the bacterial taxa that were
altered with sex and exposure. These concerns will be addressed in our future studies.
Nonetheless, the current study highlighted how sex differences play a role in dictating
toxicity endpoints caused by environmental toxicant exposures. Further studies
correlating bacterial abundance with liver disease endpoints will provide more knowledge
on how the disrupted gut-liver axis drives PCB toxicity in female mice.
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SIGNIFICANCE AND IMPACT
The findings from our current project will help in better understanding PCB effects
on the relationship between the liver and the gut microbiota (gut-liver axis), and how these
effects can be identified in PCB-exposed populations. Based on previous studies, we
have demonstrated that PCBs can contribute to fatty liver disease, and it is well-known
that there is a cross interaction between the liver and the microbiome in the gut.
Therefore, our studies will provide a more complete understanding of how PCBs can
impact the interaction between the liver and the gut. The findings on sex differences will
also help in better risk assessment of populations that may be more susceptible to PCBinduced toxicity and will better address knowledge gaps in health disparities related to
environmental pollution. Our study objective and findings are relevant to PCB-exposed
populations such as the ACHS cohort and others.
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FUTURE DIRECTIONS
We will be examining bacterial abundance within samples to identify bacterial
phyla that play a role in driving the observed PCB effects dependent on sex. In addition,
we will further explore studies looking at long-term effects of PCB exposure on gut
microbiome and gut-liver axis, and how high caloric diets such as high fat diet can
influence PCB-mediated effects. Specifically, we will investigate whether these findings
will translate to human exposures using our available human epidemiological data.

37

ACKNOWLEDGEMENTS
I would like to acknowledge the UofL Genomics Facility, which is supported, in
part, by NIH P20GM103436 (KY IDeA Networks of Biomedical Research Excellence), the
UofL J. G. Brown Cancer Center, the UofL Department of Medicine, Division of
Hepatology, Gastroenterology and Nutrition, the TriBeta Research Foundation, and the
UofL Center for Integrative Environmental Health Sciences (CIEHS) Research Voucher
Program. I would also like to acknowledge the Cave and Wahlang Lab members, as well
as Dr. Richa Singhal.

38

REFERENCES
1.

Kimbrough RD. Polychlorinated biphenyls (PCBs) and human health: an update.
Crit

Rev

Toxicol.

1995;25(2):133-63.

Epub

1995/01/01.

doi:

10.3109/10408449509021611. PubMed PMID: 7612174.
2.

Wahlang B, Falkner KC, Clair HB, Al-Eryani L, Prough RA, States JC, Coslo DM,
Omiecinski CJ, Cave MC. Human receptor activation by aroclor 1260, a
polychlorinated biphenyl mixture. Toxicol Sci. 2014;140(2):283-97. Epub
2014/05/09. doi: 10.1093/toxsci/kfu083. PubMed PMID: 24812009; PMCID:
PMC4176050.

3.

Jin J, Wahlang B, Shi H, Hardesty JE, Falkner KC, Head KZ, Srivastava S,
Merchant ML, Rai SN, Cave MC, Prough RA. Dioxin-like and non-dioxin-like PCBs
differentially regulate the hepatic proteome and modify diet-induced nonalcoholic
fatty liver disease severity. Med Chem Res. 2020;29:1247-63. Epub 2020/08/25.
doi:

10.1007/s00044-020-02581-w.

PubMed

PMID:

32831531;

PMCID:

PMC7440142.
4.

Wahlang B, Song M, Beier JI, Cameron Falkner K, Al-Eryani L, Clair HB, Prough
RA, Osborne TS, Malarkey DE, States JC, Cave MC. Evaluation of Aroclor 1260
exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver
disease. Toxicol Appl Pharmacol. 2014;279(3):380-90. Epub 2014/07/08. doi:
10.1016/j.taap.2014.06.019. PubMed PMID: 24998970; PMCID: PMC4225625.

5.

Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave
MC. Toxicant-associated steatohepatitis. Toxicol Pathol. 2013;41(2):343-60. Epub

39

2012/12/25. doi: 10.1177/0192623312468517. PubMed PMID: 23262638; PMCID:
PMC5114851.
6.

Clair HB, Pinkston CM, Rai SN, Pavuk M, Dutton ND, Brock GN, Prough RA,
Falkner KC, McClain CJ, Cave MC. Liver Disease in a Residential Cohort With
Elevated Polychlorinated Biphenyl Exposures. Toxicol Sci. 2018;164(1):39-49.
Epub 2018/04/24. doi: 10.1093/toxsci/kfy076. PubMed PMID: 29684222; PMCID:
PMC6016643.

7.

Wahlang B, Jin J, Hardesty JE, Head KZ, Shi H, Falkner KC, Prough RA, Klinge
CM, Cave MC. Identifying sex differences arising from polychlorinated biphenyl
exposures in toxicant-associated liver disease. Food Chem Toxicol. 2019;129:6476. Epub 2019/04/27. doi: 10.1016/j.fct.2019.04.007. PubMed PMID: 31026535;
PMCID: PMC6555661.

8.

Kakizaki S, Yamazaki Y, Takizawa D, Negishi M. New insights on the xenobioticsensing nuclear receptors in liver diseases--CAR and PXR. Curr Drug Metab.
2008;9(7):614-21.

Epub

2008/09/11.

doi:

10.2174/138920008785821666.

PubMed PMID: 18781913.
9.

Wahlang B, Alexander NC, 2nd, Li X, Rouchka EC, Kirpich IA, Cave MC.
Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice
exhibiting toxicant-associated steatohepatitis. Toxicol Rep. 2021;8:536-47. Epub
2021/03/30. doi: 10.1016/j.toxrep.2021.03.010. PubMed PMID: 33777700;
PMCID: PMC7985695.

10.

Wahlang B, Jin J, Beier JI, Hardesty JE, Daly EF, Schnegelberger RD, Falkner
KC, Prough RA, Kirpich IA, Cave MC. Mechanisms of Environmental Contributions

40

to Fatty Liver Disease. Curr Environ Health Rep. 2019;6(3):80-94. Epub
2019/05/28. doi: 10.1007/s40572-019-00232-w. PubMed PMID: 31134516;
PMCID: PMC6698418.
11.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time
quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):4028. Epub 2002/02/16. doi: 10.1006/meth.2001.1262. PubMed PMID: 11846609.

12.

Zhang L, Wang YD, Chen WD, Wang X, Lou G, Liu N, Lin M, Forman BM, Huang
W. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and
intestine in mice. Hepatology. 2012;56(6):2336-43. Epub 2012/06/20. doi:
10.1002/hep.25905. PubMed PMID: 22711662; PMCID: PMC3477501.

13.

Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, Nielsen J, Ley
RE, Backhed F. Analysis of gut microbial regulation of host gene expression along
the length of the gut and regulation of gut microbial ecology through MyD88. Gut.
2012;61(8):1124-31. Epub 2011/11/26. doi: 10.1136/gutjnl-2011-301104. PubMed
PMID: 22115825; PMCID: PMC3388726.

14.

Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L,
Alnouti Y, Fouts DE, Starkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L,
Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Modulation
of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis
improves alcoholic liver disease in mice. Hepatology. 2018;67(6):2150-66. Epub
2017/11/22. doi: 10.1002/hep.29676. PubMed PMID: 29159825; PMCID:
PMC5962369.

41

15.

Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease:
Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558-77. Epub
2019/10/18. doi: 10.1016/j.jhep.2019.10.003. PubMed PMID: 31622696.

16.

Petriello MC, Hoffman JB, Vsevolozhskaya O, Morris AJ, Hennig B. Dioxin-like
PCB 126 increases intestinal inflammation and disrupts gut microbiota and
metabolic

homeostasis.

Environ

Pollut.

2018;242(Pt

A):1022-32.

Epub

2018/10/31. doi: 10.1016/j.envpol.2018.07.039. PubMed PMID: 30373033;
PMCID: PMC6211811.
17.

Chi Y, Lin Y, Lu Y, Huang Q, Ye G, Dong S. Gut microbiota dysbiosis correlates
with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver
disease.

Sci

Total

Environ.

2019;653:274-82.

Epub

2018/11/10.

doi:

10.1016/j.scitotenv.2018.10.387. PubMed PMID: 30412872.
18.

Chi Y, Wang H, Lin Y, Lu Y, Huang Q, Ye G, Dong S. Gut microbiota
characterization and lipid metabolism disorder found in PCB77-treated female
mice.

Toxicology.

2019;420:11-20.

Epub

2019/04/03.

doi:

10.1016/j.tox.2019.03.011. PubMed PMID: 30935970.
19.

Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, Furlanello
C, Zandona A, Paci P, Capuani G, Dallapiccola B, Miccheli A, Alisi A, Putignani L.
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese
patients unveiled by an integrated meta-omics-based approach. Hepatology.
2017;65(2):451-64. Epub 2016/03/31. doi: 10.1002/hep.28572. PubMed PMID:
27028797.

42

20.

Pelaseyed T, Bergstrom JH, Gustafsson JK, Ermund A, Birchenough GM, Schutte
A, van der Post S, Svensson F, Rodriguez-Pineiro AM, Nystrom EE, Wising C,
Johansson ME, Hansson GC. The mucus and mucins of the goblet cells and
enterocytes provide the first defense line of the gastrointestinal tract and interact
with the immune system. Immunol Rev. 2014;260(1):8-20. Epub 2014/06/20. doi:
10.1111/imr.12182. PubMed PMID: 24942678; PMCID: PMC4281373.

21.

Rao R. Occludin phosphorylation in regulation of epithelial tight junctions. Ann N
Y

Acad

Sci.

2009;1165:62-8.

Epub

2009/06/23.

doi:

10.1111/j.1749-

6632.2009.04054.x. PubMed PMID: 19538289; PMCID: PMC6202026.
22.

Matsumoto K, Imasato M, Yamazaki Y, Tanaka H, Watanabe M, Eguchi H, Nagano
H, Hikita H, Tatsumi T, Takehara T, Tamura A, Tsukita S. Claudin 2 deficiency
reduces bile flow and increases susceptibility to cholesterol gallstone disease in
mice. Gastroenterology. 2014;147(5):1134-45 e10. Epub 2014/07/30. doi:
10.1053/j.gastro.2014.07.033. PubMed PMID: 25068494.

23.

Wang Y, Liang K, Kong W. Intestinal Trefoil Factor 3 Alleviates the Intestinal
Barrier Function Through Reducing the Expression of TLR4 in Rats with
Nonalcoholic Steatohepatitis. Arch Med Res. 2019;50(1):2-9. Epub 2019/05/19.
doi: 10.1016/j.arcmed.2019.03.004. PubMed PMID: 31101239.

24.

Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut
microbiota functions: metabolism of nutrients and other food components. Eur J
Nutr. 2018;57(1):1-24. Epub 2017/04/11. doi: 10.1007/s00394-017-1445-8.
PubMed PMID: 28393285; PMCID: PMC5847071.

43

25.

Fennema D, Phillips IR, Shephard EA. Trimethylamine and Trimethylamine NOxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome
Metabolic Axis Implicated in Health and Disease. Drug Metab Dispos.
2016;44(11):1839-50. Epub 2016/10/21. doi: 10.1124/dmd.116.070615. PubMed
PMID: 27190056; PMCID: PMC5074467.

26.

Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev
Endocr Metab Disord. 2019;20(4):461-72. Epub 2019/11/11. doi: 10.1007/s11154019-09512-0. PubMed PMID: 31707624; PMCID: PMC6938793.

44

